Aantal gebruikers 2020-2024 voor ATC-subgroep A10BJ : Glucagonachtig peptide-1-agonisten (glp-1-agonisten)
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| A10BJ01 Exenatide | 585 | 477 | 410 | 98 | 38 |
| A10BJ02 Liraglutide (Saxenda ®) | 9.893 | 8.328 | 16.665 | 23.684 | 23.644 |
| A10BJ03 Lixisenatide (Lyxumia ®) | 101 | 66 | 63 | 159 | 21 |
| A10BJ05 Dulaglutide (Trulicity ®) | 4.566 | 5.472 | 9.841 | 8.494 | 6.122 |
| A10BJ06 Semaglutide (Ozempic ®) | 26.153 | 42.219 | 62.396 | 89.372 | 116.520 |